After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, EWTX falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Edgewise Therapeutics Inc is $1.54B. A total of 1.32 million shares were traded on the day, compared to an average of 764.25K shares.
In the most recent transaction, Russell Alan J sold 100,000 shares of EWTX for 14.60 per share on Aug 26 ’25. After the transaction, the Chief Scientific Officer now owns 23,400 company shares. In a previous transaction on Aug 26 ’25, ALAN J RUSSELL bought 100,000 shares at 14.60 per share.
Among the insiders who sold shares, MOORE JOHN R disposed of 2,098 shares on Aug 12 ’25 at a per-share price of $13.39. This resulted in the General Counsel holding 10,214 shares of EWTX after the transaction. In another insider transaction, Derakhshan Behrad sold 2,491 shares at $13.39 per share on Aug 12 ’25. Company shares held by the Chief Business Officer now total 23,645.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, EWTX has a high of $38.12 and a low of $10.60.
As of this writing, EWTX has an earnings estimate of -$0.4 per share for the current quarter. EPS was calculated based on a consensus of 12.0 estimates, with a high estimate of -$0.37 per share and a lower estimate of -$0.44. The company reported an EPS of -$0.36 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. EWTX’s latest balance sheet shows that the firm has $280.79M in Cash & Short Term Investments as of fiscal 2021. There were $0.00 in debt and $10.52M in liabilities at the time. Its Book Value Per Share was $5.59, while its Total Shareholder’s Equity was $274.38M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EWTX is Buy with a score of 4.46.
